These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27418569)

  • 1. Stability-limit "Ouzo region" boundaries for poly(lactide-co-glycolide) nanoparticles prepared by nanoprecipitation.
    Beck-Broichsitter M
    Int J Pharm; 2016 Sep; 511(1):262-266. PubMed ID: 27418569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solvent selection causes remarkable shifts of the "Ouzo region" for poly(lactide-co-glycolide) nanoparticles prepared by nanoprecipitation.
    Beck-Broichsitter M; Nicolas J; Couvreur P
    Nanoscale; 2015; 7(20):9215-21. PubMed ID: 25924854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of nanoparticles by solvent displacement for drug delivery: a shift in the "ouzo region" upon drug loading.
    Beck-Broichsitter M; Rytting E; Lebhardt T; Wang X; Kissel T
    Eur J Pharm Sci; 2010 Oct; 41(2):244-53. PubMed ID: 20600881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of Histone Deacetylase Inhibitor Vorinostat-Loaded Poly D, L-Lactide-co-Glycolide Polymeric Nanoparticles by Nanoprecipitation Method.
    Ravikumar V; Sankar R
    Methods Mol Biol; 2017; 1510():399-403. PubMed ID: 27761838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan Stabilized Gold-Folate-Poly(lactide-co-glycolide) Nanoplexes Facilitate Efficient Gene Delivery in Hepatic and Breast Cancer Cells.
    Akinyelu J; Singh M
    J Nanosci Nanotechnol; 2018 Jul; 18(7):4478-4486. PubMed ID: 29442622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
    Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
    J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of exenatide in poly(D,L-lactide-co-glycolide) solutions: a simplified investigation on the peptide degradation by the polymer.
    Liang R; Zhang R; Li X; Wang A; Chen D; Sun K; Liu W; Li Y
    Eur J Pharm Sci; 2013 Nov; 50(3-4):502-10. PubMed ID: 23994054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixture designs in the optimisation of PLGA nanoparticles: influence of organic phase composition on β-aescin encapsulation.
    Ven HV; Vandervoort J; Weyenberg W; Apers S; Ludwig A
    J Microencapsul; 2012; 29(2):115-25. PubMed ID: 22047548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the Conformation of Poly(L-lactide-co-glycolide) Molecules in Organic Solvents on Nanoparticle Size.
    Takeuchi I; Kimura Y; Makino K
    J Oleo Sci; 2020 Sep; 69(9):1125-1132. PubMed ID: 32788521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrophobic boron compound-loaded poly(l-lactide-co-glycolide) nanoparticles for boron neutron capture therapy.
    Takeuchi I; Nomura K; Makino K
    Colloids Surf B Biointerfaces; 2017 Nov; 159():360-365. PubMed ID: 28806667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical characterization of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier.
    Kim IS; Lee SK; Park YM; Lee YB; Shin SC; Lee KC; Oh IJ
    Int J Pharm; 2005 Jul; 298(1):255-62. PubMed ID: 15941631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of poly lactide-co-glycolide nanoparticles of SN-38.
    Ebrahimnejad P; Dinarvand R; Sajadi SA; Atyabi F; Ramezani F; Jaafari MR
    PDA J Pharm Sci Technol; 2009; 63(6):512-20. PubMed ID: 20169857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particle size control of poly(dl-lactide-co-glycolide) nanospheres for sterile applications.
    Tsukada Y; Hara K; Bando Y; Huang CC; Kousaka Y; Kawashima Y; Morishita R; Tsujimoto H
    Int J Pharm; 2009 Mar; 370(1-2):196-201. PubMed ID: 19100320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer.
    Sankar R; Ravikumar V
    Biomed Pharmacother; 2014 Sep; 68(7):865-71. PubMed ID: 25107842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular uptake of Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles synthesized through solvent emulsion evaporation and nanoprecipitation method.
    Xiong S; Zhao X; Heng BC; Ng KW; Loo JS
    Biotechnol J; 2011 May; 6(5):501-8. PubMed ID: 21259442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuning the Size of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles Fabricated by Nanoprecipitation.
    Huang W; Zhang C
    Biotechnol J; 2018 Jan; 13(1):. PubMed ID: 28941234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charge-controlled nanoprecipitation as a modular approach to ultrasmall polymer nanocarriers: making bright and stable nanoparticles.
    Reisch A; Runser A; Arntz Y; Mély Y; Klymchenko AS
    ACS Nano; 2015 May; 9(5):5104-16. PubMed ID: 25894117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoprecipitation and the "Ouzo effect": Application to drug delivery devices.
    Lepeltier E; Bourgaux C; Couvreur P
    Adv Drug Deliv Rev; 2014 May; 71():86-97. PubMed ID: 24384372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.